What’s the Outlook for Indian Markets with RBI MPC and India-US Trade Deal Next Week?

Synopsis
Key Takeaways
- The RBI MPC meeting is set for September 29 to October 1.
- Anticipated 25-bps rate cut could impact investor decisions.
- Ongoing discussions on the India-US trade deal are promising.
- Recent FII activity shows significant equity offload.
- Investor sentiment remains cautious amid global uncertainties.
Mumbai, Sep 28 (NationPress) The upcoming week is poised to be pivotal for Indian equities as investors keep a close watch on the Reserve Bank of India’s Monetary Policy Committee (MPC) meeting, progress on the India-US trade deal, foreign institutional investor (FII) trends, and overarching global economic indicators.
The MPC meeting is set to occur from September 29 to October 1, during which the central bank is anticipated to assess interest rates.
Market analysts predict a 25-basis-point (bps) rate cut in the forthcoming policy announcement. Currently, the repo rate is at 5.5 percent.
Previously, the RBI opted to keep the policy rate steady, but since February 2025, it has reduced the repo rate by nearly one percentage point.
Attention will also be directed towards the India-US trade agreement, which is reportedly making favorable strides.
A senior Indian delegation, led by Commerce and Industry Minister Piyush Goyal, recently engaged in discussions in the US with US Trade Representative Jamison Greer and Ambassador Sergio Gor.
Additionally, FII data will be a significant influence. In the prior week, FIIs divested equities worth Rs 19,570.03 crore, while domestic institutional investors (DIIs) acquired shares valued at Rs 17,411.4 crore.
In the preceding week, the Nifty fell by 672.35 points or 2.65 percent to close at 24,654.70, whereas the Sensex saw a decline of 2,199.77 points or 2.66 percent, finishing at 80,426.46.
On Friday, both major indices continued to experience losses. The Sensex concluded 733.22 points or 0.90 percent lower at 80,426.46, while the Nifty dropped 236.15 points or 0.95 percent, closing at 24,654.70.
Analysts noted that Indian equities reflected the downturn observed across Asian markets.
“Investor sentiment was negatively impacted after new tariffs were levied on pharmaceutical companies, resulting in substantial declines in pharma stocks,” analysts commented.
Simultaneously, Accenture’s disappointing guidance and workforce reductions indicated a slowdown in IT spending, prompting a widespread sell-off in technology stocks.
In light of global uncertainties, investors are remaining vigilant and concentrating on domestic investment and consumption patterns in the near term.